Skip to main content

Table 1 Demographics, baseline characteristics and outcome of 159 patients categorized in cancer, and without cancer subgroups and 53 cancerous patients categorized into alive and dead

From: Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study

Variables

W/O cancer

N = 106 (%)a

Cancer

N = 53 (%)

p value

Cancer

p value

Alive

N = 26 (%)

Dead

N = 27 (%)

Age

 < 50

24 (22.6)

8 (15.1)

 

3 (11.5)

5 (18.5)

 

 50–65

34 (32.1)

21 (39.6)

0.453

13 (50)

8 (29.6)

0.374

 > 65

48 (45.3)

24 (45.3)

 

10 (38.5)

14 (51.9)

 

Sex

 Female

46 (43.4)

22 (41.5)

0.821

14 (53.85)

8 (29.6)

0.098

 Male

60 (56.6)

31 (58.5)

12 (46.15)

19 (70.4)

 BMIb

25.7 (23.1–29.3)

24.8 (22.4–30.4)

0.528

23.4 (21.9–29.1)

26.6 (23–31.1)

0.180

Past medical history

 DM

16 (15.1)

9 (17)

0.758

4 (15.4)

5 (18.5)

0.990

 HTN

30 (28.3)

15 (28.3)

0.990

10 (38.5)

5 (18.5)

0.135

 IHD

18 (17)

8 (15.1)

0.762

4 (15.4)

4 (14.8)

0.990

Symptoms:

 Fever

54 (50.9)

30 (56.6)

0.500

13 (50)

17 (63)

0.412

 Cough

56 (52.8)

190 (35.9)

0.043

11 (42.3)

8 (29.6)

0.398

 Dyspnea

64 (60.4)

28 (52.8)

0.364

9 (34.6)

19 (70.4)

0.013

 Chills

4 (3.8)

3 (5.7)

0.585

2 (7.7)

1 (3.7)

0.610

 Myalgia

16 (15.1)

8 (15.1)

0.990

4 (15.4)

4 (14.8)

0.990

 Nausea

8 (7.6)

15 (28.3)

0.000

10 (38.5)

5 (18.5)

0.135

 Diarrhoea

3 (2.8)

1 (1.9)

0.720

1 (3.9)

0

0.491

 Sore throat

2 (1.9)

2 (3.8)

0.474

1 (3.9)

1 (3.7)

0.990

 Fatigue

35 (33)

26 (49.1)

0.050

12 (46.2)

14 (51.9)

0.786

 Anorexia

10 (9.4)

9 (17)

0.167

7 (26.9)

2 (7.4)

0.076

 Chest pain

10 (9.4)

1 (1.9)

0.077

1 (3.9)

0

0.304

Signs:

 Low consciousness

7 (6.6)

7 (13.2)

0.166

1 (3.9)

6 (22.2)

0.100

O2Saturation

 > 96%

39 (38.6)

18 (34.6)

 

5 (20)

13 (48.2)

 

 90–96%

47 (46.5)

22 (42.3)

0.449

12 (48)

10 (37)

0.083

 < 90%

15 (14.9)

12 (23.1)

 

8 (32)

4 (14.8)

 

Systolic blood pressure (mmHg)

 < 100

4 (3.9)

9 (17)

 

4 (15.4)

5 (18.5)

 

 100–140

75 (73.5)

35 (66)

0.025

17 (65.4)

18 (66.7)

0.990

 > 140

23 (22.6)

9 (17)

 

5 (19.2)

4 (14.8)

 

Respiratory rate (/min)

  < 25

87 (86.1)

43 (81.1)

0.416

24 (92.3)

19 (70.4)

0.076

 > 25

14 (13.9)

10 (18.9)

2 (7.7)

8 (29.6)

Pulse Rate (/min)

  < 100

65 (64.4)

29 (55.8)

0.301

19 (73.1)

10 (38.5)

0.025

 > 100

36 (35.6)

23 (44.2)

 

7 (26.9)

16 (61.5)

Temperature (oc)

 < 37.8

63 (61.8)

37 (69.8)

 

20 (76.9)

17 (63)

 

 37.8–39

28 (27.4)

12 (22.6)

0.594

5 (19.2)

7 (25.9)

0.493

 > 39

11 (10.8)

4 (7.6)

 

1 (3.9)

3 (11.1)

 

qSOFA

 0

68 (64.2)

25 (47.2)

 

14 (53.9)

11 (40.7)

 

 1

35 (33)

22 (41.5)

 

11 (42.3)

11 (40.7)

 

 2

3 (2.8)

3 (5.7)

0.020

0

3 (11.1)

0.417

 3

0

3 (5.7)

 

1 (3.8)

2 (7.5)

 
  1. BMI Body mass index, DM diabetes mellitus, HTN hypertension, IHD ischemic heart disease, qSOFA quick sequential organ failure assessment
  2. a Percentages were calculated by total, survived, and non-survived patients number as denominator for each column respectively
  3. b median (IQR)